Lv11
50 积分 2023-07-21 加入
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
已完结
Chronic Thromboembolic Pulmonary Hypertension
7个月前
已完结
Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease
1年前
已完结
皖公网安备34019202002308
